China study: Malaria drug no better than regular coronavirus care

Researchers have concluded that additional studies using larger numbers of patients are needed to fully investigate the anti-malaria drug hydroxychloroquine's risks and benefits. - AFP

BEIJING (Bloomberg): Hydroxychloroquine, a medicine for malaria that US President Donald Trump has touted as a treatment for coronavirus, was no more effective than conventional care, a small study found.

The report from researchers at Zhejiang University in China showed that patients who got the medicine didn't fight off the new coronavirus more often than those who did not get the medicine.